Exact Mass: 392.0895986
Exact Mass Matches: 392.0895986
Found 455 metabolites which its exact mass value is equals to given mass value 392.0895986,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Shanziside
C16H24O11 (392.13185539999995)
Shanzhiside is a terpene glycoside. Shanzhiside is a natural product found in Barleria lupulina, Gardenia jasminoides, and other organisms with data available. Shanziside is a iridoid glucoside isolated from Phlomis tuberosa L[1]. Shanziside is a iridoid glucoside isolated from Phlomis tuberosa L[1].
Macarpine
A benzophenanthridine alkaloid that is sanguinarine bearing two methoxy substituents.
7-Ethyl-10-hydroxycamptothecin
SN-38 is a member of the class of pyranoindolizinoquinolines that is (4S)-pyrano[3,4:6,7]indolizino[1,2-b]quinoline-3,14-dione bearing two additional ethyl substituents at positions 4 and 11 as well as two additional hydroxy substituents at positions 4 and 9. It is the active metabolite of irinotecan and is ~1000 times more active than irinotecan itself. It has a role as an apoptosis inducer, an EC 5.99.1.2 (DNA topoisomerase) inhibitor, a drug metabolite and an antineoplastic agent. It is a pyranoindolizinoquinoline, a delta-lactone, a tertiary alcohol and a member of phenols. 7-ethyl-10-hydroxycamptothecin (SN 38) is a liposomal formulation of the active metabolite of Irinotecan [DB00762], a chemotherapeutic pro-drug approved for the treatment of advanced colorectal cancer. SN 38 has been used in trials studying the treatment of Cancer, Advanced Solid Tumors, Small Cell Lung Cancer, Metastatic Colorectal Cancer, and Triple Negative Breast Cancer, among others. 7-Ethyl-10-hydroxycamptothecin is a natural product found in Apis cerana with data available. A semisynthetic camptothecin derivative that inhibits DNA TOPOISOMERASE I to prevent nucleic acid synthesis during S PHASE. It is used as an antineoplastic agent for the treatment of COLORECTAL NEOPLASMS and PANCREATIC NEOPLASMS. 7-Ethyl-10-hydroxycamptothecin (SN38) is the active metabolite of irinotecan (an analog of camptothecin - a topoisomerase I inhibitor); it is 1000 times more active than irinotecan itself. In vitro cytotoxicity assays show that the potency of SN-38 relative to irinotecan varies from 2- to 2000-fold. SN38 is metabolized via glucoronidation by UGT1A1. (Wikipedia) 7-Ethyl-10-hydroxycamptothecin (SN38), the active metabolite of irinotecan, exerts a 100-fold to 1000-fold higher effect than irinotecan itself against several tumor cell lines. (PMID: 23233044) Among five chemotherapeutic agents commonly used for breast cancer treatment, only an irinotecan metabolite SN38 showed additive antitumor activity with olaparib. (PMID: 22454224) Metabolism of irinotecan to SN38 is inefficient and subject to considerable patient-to-patient variability. One approach to more controlled administration of the anticancer agent is direct administration of the active SN38. (PMID: 23299391) A member of the class of pyranoindolizinoquinolines that is (4S)-pyrano[3,4:6,7]indolizino[1,2-b]quinoline-3,14-dione bearing two additional ethyl substituents at positions 4 and 11 as well as two additional hydroxy substituents at positions 4 and 9. It is the active metabolite of irinotecan and is ~1000 times more active than irinotecan itself. SN-38 (NK012) is an active metabolite of the Topoisomerase I inhibitor Irinotecan. SN-38 (NK012) inhibits DNA and RNA synthesis with IC50s of 0.077 and 1.3 μM, respectively[1][2][3][4]. SN-38 (NK012) is an active metabolite of the Topoisomerase I inhibitor Irinotecan. SN-38 (NK012) inhibits DNA and RNA synthesis with IC50s of 0.077 and 1.3 μM, respectively[1][2][3][4].
Tiotropium
C19H22NO4S2+ (392.09901920000004)
Tiotropium is a long-acting, 24 hour, anticholinergic bronchodilator used in the management of chronic obstructive pulmonary disease (COPD). Tiotropium is a muscarinic receptor antagonist, on topical application it acts mainly on M3 muscarinic receptors located in the airways to produce smooth muscle relaxation, thus producing a bronchodilatory effect.
2-(4-benzoyl-3,5-dihydroxyphenoxy)-6-(hydroxymethyl)oxane-3,4,5-triol
Caryoptosidic acid
C16H24O11 (392.13185539999995)
Caryoptosidic acid is found in herbs and spices. Caryoptosidic acid is a constituent of Lippia graveolens (Mexican oregano) Constituent of Lippia graveolens (Mexican oregano). Caryoptosidic acid is found in herbs and spices.
Garcimangosone D
Garcimangosone D is found in fruits. Garcimangosone D is a constituent of the dried fruit hulls of Garcinia mangostana (mangosteen). Constituent of the dried fruit hulls of Garcinia mangostana (mangosteen). Garcimangosone D is found in fruits.
cyclic N-Acetylserotonin glucuronide
cyclic N-Acetylserotonin glucuronide is a metabolite of melatonin. Melatonin Listen/ˌmɛləˈtoʊnɪn/, also known chemically as N-acetyl-5-methoxytryptamine, is a naturally occurring compound found in animals, plants, and microbes. In animals, circulating levels of the hormone melatonin vary in a daily cycle, thereby allowing the entrainment of the circadian rhythms of several biological functions. (Wikipedia)
1,3-Dipropyl-8-p-sulfophenylxanthine
C17H20N4O5S (392.11543500000005)
D018377 - Neurotransmitter Agents > D058905 - Purinergic Agents > D058914 - Purinergic Antagonists
Cloprednol
Fenflumizole
C23H18F2N2O2 (392.1336271999999)
Reglitazar
C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C154291 - Peroxisome Proliferator-Activated Receptor Agonist
2,6-Dioxo-9-phenyl-1,3-dipropylpurine-8-sulfonic acid
C17H20N4O5S (392.11543500000005)
Shanzhiside
C16H24O11 (392.13185539999995)
Actos
C19H20N2O3S.HCl (392.0961346000001)
Pioglitazone hydrochloride is an aromatic ether. Pioglitazone Hydrochloride is the hydrochloride salt of an orally-active thiazolidinedione with antidiabetic properties and potential antineoplastic activity. Pioglitazone activates peroxisome proliferator-activated receptor gamma (PPAR-gamma), a ligand-activated transcription factor, thereby inducing cell differentiation and inhibiting cell growth and angiogenesis. This agent also modulates the transcription of insulin-responsive genes, inhibits macrophage and monocyte activation, and stimulates adipocyte differentiation. (NCI05) A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS. See also: Pioglitazone (has active moiety); Glimepiride; Pioglitazone Hydrochloride (component of); Alogliptin Benzoate; Pioglitazone Hydrochloride (component of). C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C98241 - Thiazolidinedione Antidiabetic Agent D007004 - Hypoglycemic Agents Pioglitazone hydrochloride is a potent and selective PPARγ agonist with EC50s of 0.93 and 0.99 μM for human and mouse PPARγ, respectively.
(1S,4aS,5R,7S,7aS)-5,7-dihydroxy-7-methyl-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4a,5,6,7a-tetrahydro-1H-cyclopenta[c]pyran-4-carboxylic acid
C16H24O11 (392.13185539999995)
Dehydrorotenone
Semiglabrin
Hosloppin
Pseudosemiglabrin
Stachyoidin
Hookerianin
Dehydrodeguelin
Dehydrodeguelin,7a,13a-Didehydrodeguelin is a member of rotenones. Dehydrodeguelin is a natural product found in Tephrosia vogelii, Derris montana, and other organisms with data available.
(2E)-1-[3-(2,3-Dihydroxybenzyl)-2,4-dihydroxy-6-methoxyphenyl]-3-phenyl-2-propen-1-one
Ethyl 7-[2-(3-cyanoanilino)-2-oxoethoxy]-4-oxo-4H-chromene-2-carboxylate
Des(methylpiperazinyl) sildenafil acid
C17H20N4O5S (392.11543500000005)
ethyl 3-[(ethoxycarbonyl)methyl]-4,6-dihydro-8,9-dihydroxy-2,6-dioxo-2H-pyrano[3,4,5-de]chromene-4-carboxylate|pomegranatate
Rhodolauradiol acetate|Rhodolauradiol monoacetate
C17H26BrClO3 (392.07537360000003)
2,4-dihydroxyphenyl-(6-O-benzoyl)-O-beta-D-glucopyranoside|Neriifolin
(-)-1,6-desoxytingtanoxide|(2R)-trans-2-acetoxy-3-(benzoyloxy)-1-<(benzoyloxy)methyl>cyclohexa-4,6-diene|(2R)-trans-2-acetoxy-3-(benzoyloxy)-1-[(benzoyloxy)methyl]cyclohexa-4,6-diene
2-C-??-D-Xylopyranosyl-1,3,6,7-tetrahydroxyxanthone
3,4-dihydroxyphenyl-(6-O-benzoyl)-O-beta-D-glucopyranoside
6,7-dihydromonotropein|dihydromonotropein
C16H24O11 (392.13185539999995)
2-chloro-3,8-dihydroxy-1,4,6,9-tetramethyl-11-oxo-11H-dibenzo[b,e][1,4]dioxepine-7-carboxylic acid methyl ester|hypophysciosporin
2-isopropenyl-3-hydroxydihydrofuranodemethylcalabaxanthone
2,4-dihydroxy-3-(2,6-dihydroxybenzyl)-6-methoxychalcone
4,5,7-trihydroxy-6-(3,4-dihydroxybenzyl)flavone|6-(3,4-dihydroxybenzyl)-5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one
1-(3-methoxy-4-hydroxybenzyl)-4-methoxyphenanthrene-2,6,7-triol
(1S,5R,7S,8S,9S)-7-acetoxy-10-chloro-5,11-dihydroxy-1-isovaleroxy-5,6-dihydrovaltrate chlorohydrin|chlorovaltrate G
5,5-Dimer-(S)-2-Amino-3-(3,4-dihydroxyphenyl)propanoic acid
1-(4-hydroxy-2-methylenebutanoate)-6-((S)-3,4-dihydroxy-2-methylenebutanoate)-beta-D-glucopyranose|tuliposide F
C16H24O11 (392.13185539999995)
[5-hydroxy-7-methoxy-2-(4-methoxyphenyl)-4-oxo-4H-chromen-8-yl]sulfonic acid monoether
pyranojacareubin
An organic heteropentacyclic compound that is 2H,6H,10H-dipyrano[3,2-b:2,3-i]xanthene substituted by hydroxy groups at positions 5 and 12, geminal methyl groups at positions 2 and 10 and an oxo group at position 6. Isolated from Calophyllum blancoi it exhibits antiviral activity.
OZESIOWEPLUEAF-QFIPXVFZSA-N
12-Ethyl-9-hydroxycamptothecin is a derivative of Camptothecin. Camptothecin (CPT), a kind of alkaloid, is a DNA topoisomerase I (Topo I) inhibitor with an IC50 of 679 nM[1].
5,9-Dimethyl-3-(3-methoxyphenyl)-psolen-6-yl propionic acid
(E)-1-[3-[(2,3-dihydroxyphenyl)methyl]-2,4-dihydroxy-6-methoxyphenyl]-3-phenylprop-2-en-1-one
[(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(4-hydroxyphenoxy)oxan-2-yl]methyl 4-hydroxybenzoate
(E)-1-[3-[(2,3-dihydroxyphenyl)methyl]-2,4-dihydroxy-6-methoxyphenyl]-3-phenylprop-2-en-1-one
[(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(4-hydroxyphenoxy)oxan-2-yl]methyl 4-hydroxybenzoate [IIN-based: Match]
Ala Ala Cys Glu
Ala Ala Glu Cys
Ala Cys Ala Glu
Ala Cys Cys Pro
Ala Cys Glu Ala
Ala Cys Pro Cys
Ala Asp Gly Met
Ala Asp Met Gly
Ala Glu Ala Cys
Ala Glu Cys Ala
Ala Gly Asp Met
Ala Gly Met Asp
Ala Met Asp Gly
Ala Met Gly Asp
Ala Pro Cys Cys
Cys Ala Ala Glu
Cys Ala Cys Pro
Cys Ala Glu Ala
Cys Ala Pro Cys
Cys Cys Ala Pro
Cys Cys Pro Ala
Cys Asp Gly Val
Cys Asp Val Gly
Cys Glu Ala Ala
Cys Gly Asp Val
Cys Gly Val Asp
Cys Pro Ala Cys
Cys Pro Cys Ala
Cys Pro Ser Ser
Cys Ser Pro Ser
Cys Ser Ser Pro
Cys Val Asp Gly
Cys Val Gly Asp
Asp Ala Gly Met
Asp Ala Met Gly
Asp Cys Gly Val
Asp Cys Val Gly
Asp Asp Gly Ser
Asp Asp Ser Gly
Asp Gly Ala Met
Asp Gly Cys Val
Asp Gly Asp Ser
Asp Gly Met Ala
Asp Gly Ser Asp
Asp Gly Val Cys
Asp Met Ala Gly
Asp Met Gly Ala
Asp Ser Asp Gly
Asp Ser Gly Asp
Asp Val Cys Gly
Asp Val Gly Cys
Glu Ala Ala Cys
Glu Ala Cys Ala
Glu Cys Ala Ala
Glu Gly Gly Met
Glu Gly Met Gly
Glu Met Gly Gly
b-D-Glucopyranuronic acid, 1-(6-methoxy-2-naphthaleneacetate)
Gly Ala Asp Met
Gly Ala Met Asp
Gly Cys Asp Val
Gly Cys Val Asp
Gly Asp Ala Met
Gly Asp Cys Val
Gly Asp Asp Ser
Gly Asp Met Ala
Gly Asp Ser Asp
Gly Asp Val Cys
Gly Glu Gly Met
Gly Glu Met Gly
Gly Gly Glu Met
Gly Gly Met Glu
Gly Met Ala Asp
Gly Met Asp Ala
Gly Met Glu Gly
Gly Met Gly Glu
Gly Ser Asp Asp
Gly Val Cys Asp
Gly Val Asp Cys
Met Ala Asp Gly
Met Ala Gly Asp
Met Asp Ala Gly
Met Asp Gly Ala
Met Glu Gly Gly
Met Gly Ala Asp
Met Gly Asp Ala
Met Gly Glu Gly
Met Gly Gly Glu
Pro Ala Cys Cys
Pro Cys Ala Cys
Pro Cys Cys Ala
Pro Cys Ser Ser
Pro Ser Cys Ser
Pro Ser Ser Cys
Ser Cys Pro Ser
Ser Cys Ser Pro
Ser Asp Asp Gly
Ser Asp Gly Asp
Ser Gly Asp Asp
Ser Pro Cys Ser
Ser Pro Ser Cys
Ser Ser Cys Pro
Ser Ser Pro Cys
Val Cys Asp Gly
Val Cys Gly Asp
Val Asp Cys Gly
Val Asp Gly Cys
Val Gly Cys Asp
Val Gly Asp Cys
Caryoptosidic acid
C16H24O11 (392.13185539999995)
Desmethyldehydroamlodipine
C19H21ClN2O5 (392.11389260000004)
Fenflumizole
C23H18F2N2O2 (392.1336271999999)
C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics C471 - Enzyme Inhibitor > C1323 - Cyclooxygenase Inhibitor D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents
2,7-Diphenyl[1]benzothieno[3,2-b][1]benzothiophene
3,5-Difluoro-4-[difluoro(3,4,5-trifluorophenoxy)methyl]-4-propyl-1,1-biphenyl
C22H17F5O (392.11994919999995)
Ethyl 2,3,4,6-tetra-O-acetyl-1-thio-b-D-galactopyranoside
3-methyl-2-[(1-methyl-2-phenyl-1H-indol-3-yl)azo]thiazolium acetate
Adenosine, 2-chloro-8-(methylamino)-, cyclic 3,5-(hydrogen phosphate)
C11H14ClN6O6P (392.04009440000004)
Parecoxib sodiuM
C19H17N2NaO4S (392.0806682000001)
D018501 - Antirheumatic Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D016861 - Cyclooxygenase Inhibitors D004791 - Enzyme Inhibitors > D016861 - Cyclooxygenase Inhibitors > D052246 - Cyclooxygenase 2 Inhibitors C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents
(S)-3-(4-(2-amino-6-chloropyrimidin-4-yl)phenyl)-2-((tert-butoxycarbonyl)amino)propanoic acid
C18H21ClN4O4 (392.12512560000005)
4-[[(3-Chloro-4-methoxyphenyl)methyl]amino]-2-[(2S)-2-(hydroxymethyl)-1-pyrrolidinyl]-5-pyrimidinecarboxylic acid
C18H21ClN4O4 (392.12512560000005)
Ethyl 2,3,4,6-tetra-O-acetyl-alpha-D-thioglucopyranoside
4-(TRIFLUOROMETHYL)UMBELLIFERYL-BETA-D-GLUCOPYRANOSIDE
ethyl 2,3,4,6-tetra-o-acetyl-a-d-thiogalactopyranoside
METHYL 1-(4-(TRIFLUOROMETHYL)PHENYL)-5-(4-(METHYLTHIO)PHENYL)-1H-PYRAZOLE-3-CARBOXYLATE
N-[2-(4-oxo-4H-3,1-benzoxazin-2-yl)phenyl]-p-toluenesulphonamide
C21H16N2O4S (392.08307360000003)
7-Amino-3-vinyl-3-cephem-4-carboxylic acid diphenylmethyl ester monohydrochloride
5-(4-METHOXYPHENYL)PYRROLO[2,1-D][1,5]BENZOTHIAZEPIN-4-OL N,N-DIMETHYLCARBAMATE
((2R,3R,4R,5R)-3-(benzoyloxy)-5-chloro-4-fluoro-4-methyltetrahydrofuran-2-yl)methyl benzoate
BIS(ETHYLCYCLOPENTADIENYL)COBALT(III)
C14H20CoF6P (392.05387220000006)
((2R,3R,4R,5S)-3-(benzoyloxy)-5-chloro-4-fluoro-4-methyltetrahydrofuran-2-yl)methyl benzoate
Ethyl 2,3,4,6-tetra-O-acetyl-b-D-thioglucopyranoside
4-(trifluoromethyl)umbelliferyl-beta-d-galactopyranoside
Chloroprednisone
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid
cloprednol
H - Systemic hormonal preparations, excl. sex hormones and insulins > H02 - Corticosteroids for systemic use > H02A - Corticosteroids for systemic use, plain > H02AB - Glucocorticoids C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid
6-(Bis-(2,2,2-trifluoroethyl)amino)-4-trifluoromethyl-1H-quinolin-2-one
C14H9F9N2O (392.05711319999995)
2-[({4-[2-(Trifluoromethyl)phenyl]piperidin-1-yl}carbonyl)amino]benzoic acid
2-Propanesulfonamide, N-((3S,4S)-4-(4-(5-cyano-2-thienyl)phenoxy)tetrahydro-3-furanyl)-
C18H20N2O4S2 (392.08644400000003)
C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent Pesampator (PF-04958242) is a potent and highly selective positive allosteric modulator of AMPA receptor (an AMPA potentiator) with an EC50 of 310 nM and a Ki of 170 nM[1].
Benzyl 6-Benzyl-5,7-Dioxo-6,7-Dihydro-5h-[1,3]thiazolo[3,2-C]pyrimidine-2-Carboxylate
C21H16N2O4S (392.08307360000003)
N-(4,5-diphenyl-2-oxazolyl)-2-[(1-methyl-5-tetrazolyl)thio]acetamide
2-(3-Methylphenyl)sulfonyl-2-[3-(1-pyrrolidinyl)-2-quinoxalinyl]acetonitrile
4-(5-methyl-2-furanyl)-2-[[1-oxo-2-(1H-1,2,4-triazol-5-ylthio)ethyl]amino]-3-thiophenecarboxylic acid ethyl ester
3-(4-Benzoyl-piperazine-1-carbonyl)-8-methoxy-chromen-2-one
3-(1-Benzimidazolylmethyl)-6-[(4-methoxyphenoxy)methyl]-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole
2-[[3-(4-methoxyphenyl)-1,2,4-oxadiazol-5-yl]methylthio]-6-phenyl-1H-pyrimidin-4-one
Methyl 6,11-dihydro-6,11-dioxo-2-ethyl-5,7,9-trihydroxy-1-naphthacenecarboxylate
3-[3-(3-Methoxyphenyl)-5,9-dimethyl-7-oxofuro[3,2-g]chromen-6-yl]propanoic acid
Tiotropium
C19H22NO4S2+ (392.09901920000004)
C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists
(4r,5r)-5-Amino-1-[2-(1,3-Benzodioxol-5-Yl)ethyl]-4-(2,4,5-Trifluorophenyl)piperidin-2-One
phosphono 4-[(2-amino-4-oxo-3H-pteridin-6-yl)methylamino]benzoate
N-Pyridoxyl-2-methyl-L-glutamic acid-5-monophosphate
Pioglitazone Hydrochloride
C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C98241 - Thiazolidinedione Antidiabetic Agent D007004 - Hypoglycemic Agents Pioglitazone hydrochloride is a potent and selective PPARγ agonist with EC50s of 0.93 and 0.99 μM for human and mouse PPARγ, respectively.
Reglitazar
C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C154291 - Peroxisome Proliferator-Activated Receptor Agonist
2-Naphthyl 6-O-(carboxyacetyl)-beta-D-glucopyranoside
3-oxo-3-[[(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-naphthalen-1-yloxyoxan-2-yl]methoxy]propanoic acid
Rhizopycnolide A
A benzochromene that is benzo[c]chromen-6-one which is substituted by hydroxy groups at positions 1, 4 and 7, methoxy groups at positions 3 and 9, a methyl group at position 1, and a 2-carboxy-2-hydroxyethyl group at position 4, and in which the carboxy group has undergone condensation with the 4-hydroxy group to afford the corresponding spirocyclic lactone. It is active against the pathogenic bacteria Agrobacterium tumefaciens, Bacillus subtilis, Pseudomonas lachrymans, Ralstonia solanacearum, Staphylococcus hemolyticus, and Xanthomonas vesicatoria, with MIC values in the range 25-100 mug/mL.
2-[[4-(4-Fluorophenyl)-6-(trifluoromethyl)-2-pyrimidinyl]sulfonyl]acetic acid ethyl ester
Cyclopentanecarboxylic acid 4-[[5-(1-naphthalenyl)-1,3,4-oxadiazol-2-yl]thio]but-2-ynyl ester
N-(2-furanylmethyl)-5-thiophen-2-yl-7-(trifluoromethyl)-2-pyrazolo[1,5-a]pyrimidinecarboxamide
N-[(E)-1-[4-[(4-chlorobenzoyl)amino]phenyl]ethylideneamino]pyridine-4-carboxamide
2-Thiophenecarboxylic acid [3-(3,5-dimethylphenoxy)-4-oxo-1-benzopyran-7-yl] ester
C22H16O5S (392.07184060000003)
4-[[[4-(2-Furanylmethyl)-5-(thiophen-2-ylmethyl)-1,2,4-triazol-3-yl]thio]methyl]benzonitrile
C20H16N4OS2 (392.07654859999997)
2-[[5,6-bis(2-furanyl)-1,2,4-triazin-3-yl]thio]-N-(3-methylphenyl)acetamide
3-(4-amino-3,5-dichlorobenzoyl)-2-(3-amino-3-oxopropyl)-2H-indazole 1-oxide
2-(1,4-dioxo-3H-phthalazin-2-yl)-N-(5-methyl-4-phenyl-2-thiazolyl)acetamide
N-[4-(9-acridinylmethyl)-3-methoxyphenyl]methanesulfonamide
3-[[(2-Cyclohexyl-1,3-dioxo-5-isoindolyl)-oxomethyl]amino]benzoic acid
N-(2-methoxyphenyl)-2-(2-oxopropylthio)-1,3-benzoxazole-5-sulfonamide
2-[[2-(5-Methyl-2-thiophenyl)-2-oxoethyl]thio]-3-phenyl-4-quinazolinone
C21H16N2O2S2 (392.06531559999996)
(2E)-5-{3-[(difluoromethyl)sulfanyl]benzyl}-2-[(2E)-(pyridin-2-ylmethylidene)hydrazinylidene]-1,3-thiazolidin-4-one
C17H14F2N4OS2 (392.05770579999995)
2-[4-(Difluoromethylthio)anilino]benzoic acid [2-(cyclopropylamino)-2-oxoethyl] ester
(4-oxopyrimido[2,1-b][1,3]benzothiazol-2-yl)methyl (E)-3-(4-methoxyphenyl)prop-2-enoate
C21H16N2O4S (392.08307360000003)
(2E)-5-[[4-(difluoromethylsulfanyl)phenyl]methyl]-2-[(E)-pyridin-3-ylmethylidenehydrazinylidene]-1,3-thiazolidin-4-one
C17H14F2N4OS2 (392.05770579999995)
2-[[5-(2-Furanyl)-4-methyl-1,2,4-triazol-3-yl]thio]-1-(1,2,3,4-tetrahydrocarbazol-9-yl)ethanone
(6R,7S,8S)-7-(4-bromophenyl)-4-[cyclobutyl(oxo)methyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one
(6S,7S,8S)-7-(4-bromophenyl)-4-[cyclobutyl(oxo)methyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one
(6R,7R,8R)-7-(4-bromophenyl)-4-[cyclobutyl(oxo)methyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one
(6S,7R,8S)-7-(4-bromophenyl)-4-[cyclobutyl(oxo)methyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one
(6S,7S,8R)-7-(4-bromophenyl)-4-[cyclobutyl(oxo)methyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one
(6S,7R,8R)-7-(4-bromophenyl)-4-[cyclobutyl(oxo)methyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one
(6R,7R,8S)-7-(4-bromophenyl)-4-[cyclobutyl(oxo)methyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one
(6R,7S,8R)-7-(4-bromophenyl)-4-[cyclobutyl(oxo)methyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one
[(2R,3S,4S,5R)-4,5-dihydroxy-2,5-bis(hydroxymethyl)oxolan-3-yl] [(3R,4S,5S)-2,4,5-trihydroxyoxan-3-yl] hydrogen phosphate
C11H21O13P (392.07197460000003)
[4-[3-[3,5-dihydroxy-4-[(E)-3-methylbut-1-enyl]phenyl]oxiran-2-yl]phenyl] hydrogen sulate
C19H20O7S (392.09296900000004)
6-[3-[(E)-but-1-enyl]-1-oxoisochromen-7-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid
6-[3-[(E)-but-1-enyl]-1-oxoisochromen-6-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid
3,4,5-trihydroxy-6-[(E)-4-(1-oxoisochromen-3-yl)but-3-enoxy]oxane-2-carboxylic acid
[(2S,3S,4S,5R,6S)-3,4,5-Trihydroxy-6-(4-hydroxyphenoxy)tetrahydropyran-2-yl]methyl 4-hydroxybenzoate
7-ethyl-10-hydroxycamptothecin
agrocinopine B
C11H21O13P (392.07197460000003)
A member of the class of agrocinopines that consists of beta-D-fructose and L-arabinose units joined via a phosphodiester linkage between position 4 of fructose and position 2 of arabinose.
2-(4-benzoyl-3,5-dihydroxyphenoxy)-6-(hydroxymethyl)oxane-3,4,5-triol
8-(5,5-dimethyl-4-oxofuran-3-yl)-5,7-dimethoxy-2-phenylchromen-4-one
2,4,7-trihydroxy-2-(2-oxopropyl)-2',4'-dioxaspiro[indene-1,3'-tricyclo[7.3.1.0⁵,¹³]tridecane]-1'(13'),5',7',9',11'-pentaen-3-one
16,17-dimethoxy-6-(prop-1-en-2-yl)-2,7,20-trioxapentacyclo[11.8.0.0³,¹¹.0⁴,⁸.0¹⁴,¹⁹]henicosa-1(13),3,8,10,14,16,18-heptaen-12-one
11,22-dihydroxy-7,7,19,19-tetramethyl-2,8,20-trioxapentacyclo[12.8.0.0³,¹².0⁴,⁹.0¹⁶,²¹]docosa-1(22),3,5,9,11,14,16(21),17-octaen-13-one
methyl 6-[6-(but-2-en-2-yl)-2,4-dihydroxy-3-methylphenoxy]-3-chloro-4-hydroxy-2-methylbenzoate
C20H21ClO6 (392.10265960000004)
(1s,3r,4r,5r)-1,3,4-trihydroxy-5-{[(2e)-3-(5-methoxy-1-benzofuran-6-yl)prop-2-enoyl]oxy}cyclohexane-1-carboxylic acid
(2r,3s)-2-[(3,4-dihydroxyphenyl)methyl]-2-hydroxy-3-(4-hydroxybenzoyloxy)butanedioic acid
5-hydroxy-7-(hydroxymethyl)-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,6h,7h,7ah-cyclopenta[c]pyran-4-carboxylic acid
C16H24O11 (392.13185539999995)
(12r,15s,16s)-14,14-dimethyl-6-oxo-4-phenyl-3,11,13-trioxatetracyclo[8.6.0.0²,⁷.0¹²,¹⁶]hexadeca-1,4,7,9-tetraen-15-yl acetate
[(2r,3s,4s,5r,6s)-6-(3,4-dihydroxyphenoxy)-3,4,5-trihydroxyoxan-2-yl]methyl benzoate
n-{3-[2-amino-3-(4-hydroxyphenoxy)phenyl]-3-oxopropyl}-4-hydroxybenzamide
(2r,3s,4r,5r,6s)-2-(2-benzoyl-3,5-dihydroxyphenoxy)-6-(hydroxymethyl)oxane-3,4,5-triol
(4ar,7r,7ar)-5,7-dihydroxy-7-methyl-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,6h,7ah-cyclopenta[c]pyran-4-carboxylic acid
C16H24O11 (392.13185539999995)
2'-acetyl-5-[2-(3,4-dihydroxyphenyl)ethenyl]-5',6'-dihydroxyspiro[furan-2,1'-inden]-3-one
2-c-β-d-xylopyranosyl-1,3,6,7-tetrahydroxy-xanthone
{"Ingredient_id": "HBIN005454","Ingredient_name": "2-c-\u03b2-d-xylopyranosyl-1,3,6,7-tetrahydroxy-xanthone","Alias": "NA","Ingredient_formula": "C18H16O10","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "22825","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
2-{6,8-dihydroxy-7-methoxy-1-methyl-4,9-dioxobenzo[f]isoindol-2-yl}benzenecarboximidic acid
[(2r,3s,4s,5r,6s)-6-(2,4-dihydroxyphenoxy)-3,4,5-trihydroxyoxan-2-yl]methyl benzoate
[3,4,5-tris(acetyloxy)-6-ethoxythian-2-yl]methyl acetate
{3,4,5-trihydroxy-6-[(4-hydroxy-2-methylidenebutanoyl)oxy]oxan-2-yl}methyl 3,4-dihydroxy-2-methylidenebutanoate
C16H24O11 (392.13185539999995)
(1s,2s,3's,4r,4's,6's)-3'-bromo-4'-chloro-1,3,3,4'-tetramethyl-7-oxaspiro[bicyclo[2.2.1]heptane-2,1'-cyclohexan]-6'-yl acetate
C17H26BrClO3 (392.07537360000003)
(1s,4as,5r,7s,7as)-5,7-dihydroxy-7-methyl-1-{[(2s,3s,4r,5s,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,6h,7ah-cyclopenta[c]pyran-4-carboxylic acid
C16H24O11 (392.13185539999995)
2-(3-chloro-2-hydroxyphenyl)-3,5,7,8-tetramethoxychromen-4-one
2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-8-[(4-hydroxyphenyl)methyl]chromen-4-one
(1r)-1-(5,8-dihydroxy-1,4-dioxonaphthalen-2-yl)-4-methylpent-3-en-1-yl benzoate
2,12,14,17-tetrahydroxy-4,9,9-trimethylpentacyclo[13.3.1.0⁵,¹⁸.0⁸,¹⁷.0¹¹,¹⁶]nonadeca-1,3,5(18),7,11,13,15-heptaene-6,10,19-trione
[(2r,3s,4s,5r,6s)-3,4,5-trihydroxy-6-[(2-methyl-4-oxopyran-3-yl)oxy]oxan-2-yl]methyl benzoate
1,3,6,7-tetrahydroxy-2-(3,4,5-trihydroxyoxan-2-yl)xanthen-9-one
(6r)-16,17-dimethoxy-6-(prop-1-en-2-yl)-2,7,20-trioxapentacyclo[11.8.0.0³,¹¹.0⁴,⁸.0¹⁴,¹⁹]henicosa-1(13),3,8,10,14,16,18-heptaen-12-one
7-hydroxy-7-(hydroxymethyl)-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,6h,7ah-cyclopenta[c]pyran-4-carboxylic acid
C16H24O11 (392.13185539999995)
7,9,11,12,14-pentahydroxy-13-methyl-12-(3-methyloxirane-2-carbonyl)-15-oxatetracyclo[8.4.1.0¹,¹⁰.0³,⁸]pentadeca-3,5,7-trien-2-one
[6-(3,4-dihydroxyphenoxy)-3,4,5-trihydroxyoxan-2-yl]methyl benzoate
9,9-dimethyl-16-oxo-14-phenyl-5,8,13-trioxatetracyclo[10.4.0.0²,⁶.0⁷,¹¹]hexadeca-1(12),2(6),3,14-tetraen-10-yl acetate
3-hydroxy-7-(hydroxymethyl)-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,3h,4h,4ah,7h,7ah-cyclopenta[c]pyran-4-carboxylic acid
C16H24O11 (392.13185539999995)
(1r,2r,3'r,4s,4'r,6'r)-3'-bromo-4'-chloro-1,3,3,4'-tetramethyl-7-oxaspiro[bicyclo[2.2.1]heptane-2,1'-cyclohexan]-6'-yl acetate
C17H26BrClO3 (392.07537360000003)
3-hydroxy-5-(2-hydroxy-2-{9-oxo-2h,3h-[1,4]dioxino[2,3-h]chromen-2-yl}propyl)-3-(hydroxymethyl)oxolan-2-one
(1s,4as,5r,7s,7ar)-5-hydroxy-7-(hydroxymethyl)-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,6h,7h,7ah-cyclopenta[c]pyran-4-carboxylic acid
C16H24O11 (392.13185539999995)
[3,4,5-trihydroxy-6-(4-hydroxyphenoxy)oxan-2-yl]methyl 4-hydroxybenzoate
[6-(2,4-dihydroxyphenoxy)-3,4,5-trihydroxyoxan-2-yl]methyl benzoate
2-[(3,4-dihydroxyphenyl)methyl]-2-hydroxy-3-(4-hydroxybenzoyloxy)butanedioic acid
1-{3-[(2,6-dihydroxyphenyl)methyl]-2,4-dihydroxy-6-methoxyphenyl}-3-phenylprop-2-en-1-one
5-hydroxy-2-(4-hydroxyphenyl)-8-[(2-hydroxyphenyl)methyl]-7-methoxy-2,3-dihydro-1-benzopyran-4-one
2,5-dihydroxy-3-(4-hydroxyphenyl)-6-{4-[(3-methylbut-2-en-1-yl)oxy]phenyl}cyclohexa-2,5-diene-1,4-dione
(17r)-2,12,14,17-tetrahydroxy-4,9,9-trimethylpentacyclo[13.3.1.0⁵,¹⁸.0⁸,¹⁷.0¹¹,¹⁶]nonadeca-1,3,5(18),7,11,13,15-heptaene-6,10,19-trione
(2s,3r,4s,5s,6r)-2-(2-benzoyl-3,5-dihydroxyphenoxy)-6-(hydroxymethyl)oxane-3,4,5-triol
1,3,6,7-tetrahydroxy-2-[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]xanthen-9-one
(12r,15r,16s)-14,14-dimethyl-6-oxo-4-phenyl-3,11,13-trioxatetracyclo[8.6.0.0²,⁷.0¹²,¹⁶]hexadeca-1,4,7,9-tetraen-15-yl acetate
(17s,18r)-13,15,18-trihydroxy-14-(1-hydroxyethylidene)-17-methyl-8-oxapentacyclo[10.6.2.0²,⁷.0⁹,¹⁹.0¹⁶,²⁰]icosa-1,4,6,9,12,15,19-heptaene-3,11-dione
(1s,4as,7r,7as)-7-hydroxy-7-(hydroxymethyl)-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,6h,7ah-cyclopenta[c]pyran-4-carboxylic acid
C16H24O11 (392.13185539999995)
(1s,3s,4s,4'r)-1,4',7-trihydroxy-3,9-dimethoxy-1-methyl-2,3-dihydrospiro[benzo[c]chromene-4,2'-oxolane]-5',6-dione
(1s,4ar,6s,7r,7ar)-4a,6,7-trihydroxy-7-methyl-1-{[(2s,3s,4r,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,5h,6h,7ah-cyclopenta[c]pyran-4-carbaldehyde
C16H24O11 (392.13185539999995)
(2s,14s,28s)-28-hydroxy-1,4,11,20-tetraazaheptacyclo[13.11.1.1²,¹⁴.0³,¹².0⁵,¹⁰.0¹⁹,²⁷.0²¹,²⁶]octacosa-3,5,7,9,11,15(27),17,19,21,23,25-undecaen-16-one
C24H16N4O2 (392.12731959999996)
1,4',7-trihydroxy-3,9-dimethoxy-1-methyl-2,3-dihydrospiro[benzo[c]chromene-4,2'-oxolane]-5',6-dione
methyl 2-ethyl-5,7,10-trihydroxy-6,11-dioxotetracene-1-carboxylate
10,15-dihydroxy-7,7,19,19-tetramethyl-2,8,20-trioxapentacyclo[12.8.0.0³,¹².0⁴,⁹.0¹⁶,²¹]docosa-1(22),3,5,9,11,14,16(21),17-octaen-13-one
ethyl 4-(2-ethoxy-2-oxoethyl)-11,12-dihydroxy-3,8-dioxo-2,7-dioxatricyclo[7.3.1.0⁵,¹³]trideca-1(12),4,9(13),10-tetraene-6-carboxylate
(1s,3s,4s,4as,7s,7as)-3-hydroxy-7-(hydroxymethyl)-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,3h,4h,4ah,7h,7ah-cyclopenta[c]pyran-4-carboxylic acid
C16H24O11 (392.13185539999995)
2-[3,5-dihydroxy-2-(4-hydroxybenzoyl)phenoxy]-6-methyloxane-3,4,5-triol
(2r)-2,4,7-trihydroxy-2-(2-oxopropyl)-2',4'-dioxaspiro[indene-1,3'-tricyclo[7.3.1.0⁵,¹³]tridecane]-1'(13'),5',7',9',11'-pentaen-3-one
2'-acetyl-5-[(1e)-2-(3,4-dihydroxyphenyl)ethenyl]-5',6'-dihydroxyspiro[furan-2,1'-inden]-3-one
4a,6,7-trihydroxy-7-methyl-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,5h,6h,7ah-cyclopenta[c]pyran-4-carbaldehyde
C16H24O11 (392.13185539999995)
(2s,4r,7r,8s,12r)-7,8,11-trihydroxy-12-(hydroxymethyl)-2-methyl-2-[(2r)-3-methyl-5-oxo-2h-furan-2-yl]-9-methylidene-5-oxatricyclo[6.3.1.0⁴,¹²]dodec-1(11)-ene-6,10-dione
5,7-dihydroxy-3,6,8-trimethoxy-2-(3,4,5-trihydroxyphenyl)chromen-4-one
(6s)-16,17-dimethoxy-6-(prop-1-en-2-yl)-2,7,20-trioxapentacyclo[11.8.0.0³,¹¹.0⁴,⁸.0¹⁴,¹⁹]henicosa-1(13),3,8,10,14,16,18-heptaen-12-one
(7s,10r,11s)-9,9-dimethyl-16-oxo-14-phenyl-5,8,13-trioxatetracyclo[10.4.0.0²,⁶.0⁷,¹¹]hexadeca-1(12),2(6),3,14-tetraen-10-yl acetate
(11s,11as)-2-acetyl-11-(7-methoxy-2h-1,3-benzodioxol-5-yl)-1h,11h,11ah-pyrazino[1,2-b]isoquinolin-6-one
[(2r,3s,4s,5s,6r)-3,4,5-tris(acetyloxy)-6-ethoxythian-2-yl]methyl acetate
(2s)-5-hydroxy-2-(4-hydroxyphenyl)-6-[(2-hydroxyphenyl)methyl]-7-methoxy-2,3-dihydro-1-benzopyran-4-one
(17r,18s)-13,15,18-trihydroxy-14-(1-hydroxyethylidene)-17-methyl-8-oxapentacyclo[10.6.2.0²,⁷.0⁹,¹⁹.0¹⁶,²⁰]icosa-1,4,6,9,12,15,19-heptaene-3,11-dione
[(2r,3s,4r,5r,6s)-6-(2,4-dihydroxyphenoxy)-3,4,5-trihydroxyoxan-2-yl]methyl benzoate
(2e)-1-{3-[(2,6-dihydroxyphenyl)methyl]-2,4-dihydroxy-6-methoxyphenyl}-3-phenylprop-2-en-1-one
2-{16-hydroxy-18-thia-2,12,15-triazapentacyclo[11.7.1.0³,⁸.0⁹,²¹.0¹⁴,¹⁹]henicosa-1(20),3,5,7,9(21),10,12,14(19),15-nonaen-20-yl}-n,n-dimethylethanamine oxide
17,18-dimethoxy-7,7-dimethyl-2,8,21-trioxapentacyclo[12.8.0.0³,¹².0⁴,⁹.0¹⁵,²⁰]docosa-1(14),3,5,9,11,15(20),16,18-octaen-13-one
(1s,3r,4s,4'r)-1,4',7-trihydroxy-3,9-dimethoxy-1-methyl-2,3-dihydrospiro[benzo[c]chromene-4,2'-oxolane]-5',6-dione
(1s,4as,6s,7r,7as)-6,7-dihydroxy-7-methyl-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,6h,7ah-cyclopenta[c]pyran-4-carboxylic acid
C16H24O11 (392.13185539999995)
[6-(acetyloxy)-5-(benzoyloxy)cyclohexa-1,3-dien-1-yl]methyl benzoate
(2s,7r)-10-acetyl-5,11,13-trihydroxy-7-methoxy-2,12-dimethyl-3-oxo-8-oxatricyclo[7.4.0.0²,⁷]trideca-1(13),4,9,11-tetraen-4-yl acetate
[(2r,3s,4s,5r,6s)-3,4,5-trihydroxy-6-[(4-hydroxy-2-methylidenebutanoyl)oxy]oxan-2-yl]methyl (3s)-3,4-dihydroxy-2-methylidenebutanoate
C16H24O11 (392.13185539999995)
(2s,3r,4s,5s,6r)-2-(4-benzoyl-3,5-dihydroxyphenoxy)-6-(hydroxymethyl)oxane-3,4,5-triol
11,21-dihydroxy-7,7,18,18-tetramethyl-2,8,19-trioxapentacyclo[12.8.0.0³,¹².0⁴,⁹.0¹⁵,²⁰]docosa-1(22),3,5,9,11,14,16,20-octaen-13-one
(2s)-5-hydroxy-2-(4-hydroxyphenyl)-8-[(2-hydroxyphenyl)methyl]-7-methoxy-2,3-dihydro-1-benzopyran-4-one
10-acetyl-5,11,13-trihydroxy-7-methoxy-2,12-dimethyl-3-oxo-8-oxatricyclo[7.4.0.0²,⁷]trideca-1(13),4,9,11-tetraen-4-yl acetate
6-[(3,4-dihydroxyphenyl)methyl]-5,7-dihydroxy-2-(4-hydroxyphenyl)chromen-4-one
(1s,3r,4r,5r)-1,3,4-trihydroxy-5-{[3-(5-methoxy-1-benzofuran-6-yl)prop-2-enoyl]oxy}cyclohexane-1-carboxylic acid
10,22-dihydroxy-7,7,18,18-tetramethyl-8,13,17-trioxapentacyclo[12.8.0.0³,¹².0⁴,⁹.0¹⁶,²¹]docosa-1(22),3,5,9,11,14,16(21),19-octaen-2-one
[(2s,3r,4r,5s,6r)-3,4,5-trihydroxy-6-(4-hydroxyphenoxy)oxan-2-yl]methyl 4-hydroxybenzoate
[(5r,6r)-6-(acetyloxy)-5-(benzoyloxy)cyclohexa-1,3-dien-1-yl]methyl benzoate
(2r)-5-hydroxy-2-(4-hydroxyphenyl)-8-[(2-hydroxyphenyl)methyl]-7-methoxy-2,3-dihydro-1-benzopyran-4-one
3'-bromo-4'-chloro-1,3,3,4'-tetramethyl-7-oxaspiro[bicyclo[2.2.1]heptane-2,1'-cyclohexan]-6'-yl acetate
C17H26BrClO3 (392.07537360000003)
(3r,5r)-3-hydroxy-5-[(2r)-2-hydroxy-2-[(2s)-9-oxo-2h,3h-[1,4]dioxino[2,3-h]chromen-2-yl]propyl]-3-(hydroxymethyl)oxolan-2-one
5-hydroxy-2-(4-hydroxyphenyl)-6-[(2-hydroxyphenyl)methyl]-7-methoxy-2,3-dihydro-1-benzopyran-4-one
ethyl (6r)-4-(2-ethoxy-2-oxoethyl)-11,12-dihydroxy-3,8-dioxo-2,7-dioxatricyclo[7.3.1.0⁵,¹³]trideca-1(12),4,9(13),10-tetraene-6-carboxylate
2-{7-oxo-2h,3h-furo[3,2-g]chromen-2-yl}propan-2-yl (2e)-3-(4-hydroxyphenyl)prop-2-enoate
13,15,18-trihydroxy-14-(1-hydroxyethylidene)-17-methyl-8-oxapentacyclo[10.6.2.0²,⁷.0⁹,¹⁹.0¹⁶,²⁰]icosa-1,4,6,9,12,15,19-heptaene-3,11-dione
28-hydroxy-1,4,11,20-tetraazaheptacyclo[13.11.1.1²,¹⁴.0³,¹².0⁵,¹⁰.0¹⁹,²⁷.0²¹,²⁶]octacosa-3,5,7,9,11,15(27),17,19,21,23,25-undecaen-16-one
C24H16N4O2 (392.12731959999996)
(2s,3r,4r,5r,6s)-2-[3,5-dihydroxy-2-(4-hydroxybenzoyl)phenoxy]-6-methyloxane-3,4,5-triol
methyl 6-{6-[(2e)-but-2-en-2-yl]-2,4-dihydroxy-3-methylphenoxy}-3-chloro-4-hydroxy-2-methylbenzoate
C20H21ClO6 (392.10265960000004)